CURRENT TEAM Mark Howarth, Professor

Mark did graduate work in molecular immunology at Oxford University Institute of Molecular Medicine and Southampton

University Cancer Sciences. In his postdoctoral work at MIT he developed tools in chemical biology, advanced microscopy and

nanotechnology to understand receptor trafficking. He was Professor of Protein Nanotechnology at Oxford University, moving to

Cambridge University to take up the Sheild Chair in the Department of Pharmacology in 2022. In 2017 he was awarded the Royal

Society of Chemistry Norman Heatley Prize for chemical biology and helped to found SpyBiotech, taking the group’s vaccine

approach into clinical trials. Several of the lab’s alumni have founded their own companies, with Mark acting as Translational

Champion for the Department. His work has been funded by ERC, BBSRC, EPSRC, MRC, Wellcome Trust and through

collaborations with companies including Genzyme, AB Vista and Sony.

Claudia Driscoll, DPhil student

Claudia did her undergraduate training at Durham University and joined the Interdisciplinary Bioscience DTP. She is developing

new antibody architectures.

Anthony Keeble, PhD from UEA

Anthony is applying library selection and structure-based design to the engineering of fast-reacting and unbreakable protein

interactions.

Cameron Anderson, DPhil student

Cameron did his MBiochem in Oxford, working on computational biochemistry, and is part of the Interdisciplinary Biosciences

Doctoral Training Programme. He has an iCASE studentship with AB Vista and is establishing evolutionary platforms and proteins

allowing targeting in the gastrointestinal system.

Miha Renko, PhD from Jozef Stefan Institute

Miha originally trained in Slovenia and has been in Cambridge for many years, working on structural biology and protein

engineering. He is now establishing targeting and therapeutic platforms for the gastrointestinal tract.

Jun Chong Ma, Part II student

JC is advancing bispecific antibody technology.

Dominic Wood, DPhil student

Dominic studied Biology at the University of York and took part in the iGEM competition in 2017. He is currently on the

Interdisciplinary Bioscience DTP.

Rory Hills, DPhil student

Rory studied at the University of Victoria, Canada where he established the University Synthetic Biology club and devised analytical

technology related to the opioid overdose crisis. He is a Rhodes Scholar, developing new vaccine technologies.

Gabrielle Admans, PhD student

Gabrielle did her Masters at the University of Glasgow, including a year’s placement with GlaxoSmithKline. She is currently

establishing platforms to enhance vaccine generation.

Tom Cowan, Part II student

Tom is studying how to improve therapeutic delivery using red blood cells.

Sandra Oloketuyi

Sandra did her Bachelors and Masters training in Nigeria, before moving to Ario de Marco’s group for her PhD on biosensor

generation. She is currently creating switchable protein technologies.

Dawid Maciorowski, MD/PhD student

Dawid is a member of the NIH OxCam scholars programme, carrying out his clinical training at the University of Wisconsin-

Madison, as well as research jointly at NIH and with our lab on HSV vaccine development.

Lasya Vankayala, DPhil student

Lasya studied at the University of British Columbia, where she founded COVID19 Demystified, and is developing covalent

conjugation to enhance cell therapy.

For information on joining this lab.

FIND FORMER MEMBERS

Anne-Marie Andersson, CTO at vaccine/immunotherapy spin-out InProTher

Kanlaya Prapainop Katewongsa, Assistant Prof. at Mahidol University, Thailand

Miriam O’Duill, Assistant Prof. at University of Nottingham

Niels Wicke, CSO and Co-founder at Inulox

Theodora Bruun, MD/PhD at Stanford Medical School

Denis Krndija, Group leader at Centre de Biologie Intégrative (CBI), Toulouse

Robert Wieduwild, researcher at Rudolf-Schönheimer-Institut für Biochemie, University of Leipzig, and founder of

spin-out denovoMATRIX

Apurba Koner, Associate Prof. at Indian Institute of Science Education and Research

Rolle Rahikainen, Career Development Fellow at University of Tampere

Bijan Zakeri, at Oxford Nanopore

Irsyad Khairil Anuar, founder at LiliumX

Arne Scheu, founder at LiliumX

Sarah Rouse UKRI Future Leaders Fellow at Imperial College London

Jacob Fierer, Director of Business Development, Technology transfer

at Weizmann Institute

Gianluca Veggiani, Assistant Professor at Louisiana State University

Michael Fairhead at the Centre for Medicines Discovery, University of Oxford

Paul Moody at Oxford Nanopore

Catharina Melzer, Senior Consultant at Bayer

Alberto Carella at Kilburn & Strode Attorneys

Jayati Jain, Executive Director at Fluid AI, co-founder with Trutech Webs and the Fluid Motion

Anselm Schneider at Nuvisan Pharma

Felix Metzner, Gene Center at Ludwig Maximilian University of Munich

Christopher Schoene at Hoffmann Eitle Patent

Emily Chittock at Carpmaels & Ransford Intellectual Property

Linda Tchatchouang at GenScript

Sam Stokes at UK Intellectual Property Office

Sheryl Lim at Fred Hutchinson Cancer Research Center

David Schramm at Oxford University Medical School

James Ross at University of Leeds

Karl Brune, Crick Institute and founder at Genie Biotech

Can Buldun at BB Biotech investment

Anthony Walsh at Lyfe Capital

Max Jamilly, Co-founder at Hoxton Farms

Susan Vester at King’s College London

Raphael Gayet in Jim Collins lab at MIT

Georgi Nikov at Imperial College

Michael Jacobsen at Novo Nordisk

Anusuya Banerjee, Senior Scientist at GSK